# 1. Financial Performance ## A. Key Figures * GDP Growth: 7.4% Q4 FY2025 · 6.5% full-year FY2025 * GDPI: ₹77.35 billion (₹773.5 Cr) Q1 FY2026 (+6%) · Industry: +8.8% * **PAT:** **₹747 Cr** Q1 FY2026 (+7%) · **PBT:** **₹994 Cr** (+4%) * ROAE: 20.5% Q1 FY2026 (vs. 19.1% YoY) * **Investment Assets:** **₹55,453 Cr** as of Jun-25 (vs. ₹53,508 Cr Mar-25) * Solvency Ratio: 2.70x (Jun-25) vs. 2.69x (Mar-25), well above 1.50x regulatory minimum * Investment Leverage: 3.74x (net of borrowings), unchanged ## B. GDPI Growth * **Below-Industry Top-Line Growth:** Company’s GDPI expansion lagged the industry in Q1 FY2026, though outperformed when volatile segments (Crop, Mass Health) were excluded, signaling **resilience in core book**. * **Macroeconomic Tailwinds:** Favorable policy environment—**repo rate cut (50 bps)**, tax incentives, and strong infrastructure momentum—is supporting demand in key industrial segments. * **Health Segment Dominance:** Remains the largest contributor to industry GDPI mix, driven by rising medical costs and credit expansion, with **2% share in Q1 FY2026**. * **Long-Term Growth Context:** Industry has grown ~15% since de-tariffing; company’s historical growth slightly lower but more recent profit trends show divergence in favor of earnings quality. ## C. Profitability Trends * **Strong Earnings Outperformance:** Despite modest revenue growth, PAT rose **7% YoY** and PBT **4% YoY**, underpinned by **robust capital gains (₹380 Cr vs. ₹284 Cr)** and disciplined underwriting. * **Superior Profit CAGR:** Company’s **~20% profit CAGR** significantly exceeds industry’s **8–10%**, reinforcing confidence in operational agility and capital efficiency. ## D. Investment Assets * **Portfolio Expansion:** Investment assets increased by **₹1,945 Cr** in Q1, reflecting continued deployment into yield-bearing instruments amid stable leverage. ## E. Solvency & Leverage * **Healthy Capital Buffer:** Solvency ratio improved to **70x**, above regulatory minimum, while investment leverage held steady at **74x**, indicating disciplined balance sheet management. --- # 2. Product & Segment Performance ## A. Key Figures * **Health Segment GDPI:** **₹2,381 Cr** Q1 FY2026 (+9%) * **Motor Segment GDPI:** **₹2,444 Cr** Q1 FY2026 (+2%) * **Property & Casualty GDPI:** **₹2,677 Cr** Q1 FY2026 (+6.8%) * **Advance Premium (Motor):** **₹3,807 Cr** as of Jun 30, 2025 · ₹3,717 Cr as of Mar 31, 2025 ## B. Health Segment Mix * **Divergent Segment Trends:** Health growth masked contrasting dynamics—**Retail Health** showed strong double-digit momentum, while **Group Health** declined due to credit constraints and 1/n accounting impact. * **Market Share Gains in Retail:** Retail Health gained share to **5%** amid product innovation and distribution expansion, driven by successful **Elevate** offering attracting new and portable customers. * **Group Health Under Pressure:** Group Health contracted with **1% market share**, pressured by competitive intensity and muted disbursements; outlook hinges on rebidding outcome in key state like **Maharashtra**. * **Industry Alignment on Long-Term Policies:** Market remains largely unified on long-term health products, with **no major behavioral shift** post-policy change, though structuring flexibility persists. ## C. Motor Portfolio Shift * **Strategic De-Risking in Motor:** Motor growth lagged industry despite **5% market share**, reflecting a deliberate pullback from unprofitable segments amid intense pricing pressure and elevated combined ratios. * **Portfolio Rebalancing:** Strategic shift away from Commercial Vehicles (down to **2% mix**) toward Private Cars (up to **8%**), driven by adverse TP pricing and competitive de-growth in CVs. * **Lower Rollover Rates:** Policy renewal trends weakened compared to prior quarters, though portability data remains undisclosed. ## D. Commercial Lines Growth * **Selective Growth with Discipline:** Commercial lines grew **8%**, outpacing a flat industry, supported by **improved pricing in Property** and strong performance in **Electric Three-wheelers**, despite zero growth in broader Commercial Vehicle segment. * **Profitability Over Scale:** Growth underpinned by granular risk selection and distribution strength, prioritizing underwriting discipline amid mixed sub-segment pricing trends. --- # 3. Demand & Pricing Trends ## A. Key Figures * Private Car Sales: 0.97 million units sold (+2.6%) * Auto Segment Trends: -1.5% YoY (Private Car, SIAM) · -7.2% YoY (Two-wheeler, SIAM) · +4.9% YoY (Overall, FADA) ## B. Auto Industry Demand * **Divergent Signals:** Auto demand shows mixed trends, with strong private car growth amid broader SIAM-reported declines, while FADA data reflects resilient overall industry performance. * **Rural Momentum:** Normal monsoon forecast expected to lift rural consumption, providing tailwinds to auto sales and motor insurance volumes. ## C. Pricing Discipline * **Underwriting Prudence:** Management maintained disciplined pricing despite limited market-wide improvement, pivoting to distribution-led growth to counter prior year’s aggressive corporate risk pricing. * **Profitability Focus:** Improved pricing sentiment supports more profitable growth, though industry discipline remains uneven. ## D. TP Hike Outlook * **Regulatory Anticipation:** Industry awaits potential Motor Third-Party price revision after four years of stagnation, with ICICI Lombard remaining neutral but optimistic about sector-wide underwriting relief. * **Competitive Sensitivity:** In CV segment, any price hike could trigger growth acceleration or pullback depending on rivals’ cost-of-acquisition strategies. --- # 4. Distribution & Channels ## A. Key Figures * **Agent & Point of Sale Network:** **143,675** as of Jun-25 (from 140,736 in Mar-25) * **Digital Service Engagement:** **38%** in Q1 FY2026 (from 22% in Q1 FY2025) * IL TakeCare App Downloads: 16.6 Mn (with 21% YoY increase in visitors · 69% YoY rise in fresh business) * Preferred Partner Network Share: 74.6% in non-OEM motor claims (from 72.0% in Q1 FY2025) ## B. Agent Network Growth * **Expanding Physical Reach:** Distribution footprint grew by nearly 3,000 outlets in one quarter, signaling aggressive ground-level expansion and rural penetration. ## C. Digital Engagement * **Digital Momentum Accelerates:** Robust adoption of digital channels driven by AI, voice bots, and targeted campaigns, with more than one-third of services now digital. * **App-Led Growth Engine:** The **IL TakeCare App** has become a key growth driver, delivering strong YoY increases in traffic and new business generation. * **Operational Efficiency Gains:** The 'One IL One Team' initiative boosted productivity by **78%** in Q1 FY2026, while reducing headcount in acquisition and service teams. * **Strategic Customer Focus:** Emphasis on retaining existing customers and acquiring new-to-insurance segments, building on prior fiscal strategies. ## D. Preferred Partner Network * **Claims Efficiency Breakthrough:** Rapid scaling of Preferred Partner Network in non-OEM motor claims, now representing **6%** of volume, up from zero a year ago. * **Partner Alignment Strengthens:** Long-term partner policies are fostering market stability and mutual value creation. --- # 5. Claims & Underwriting Metrics ## A. Key Figures * Combined Ratio (CoR): 112.6% industry FY2025 (from 112.0%) · 111.4% private players FY2025 (from 108.7%) · 102.8% company FY2025 (improved from 103.3%) * **Q1 FY2026 CoR:** **102.9%** (vs. 102.3% in Q1 FY2025) * Corporate Health Loss Ratio: 95.7% Q1 FY2026 (from 97.9%) · Retail Indemnity: 74.3% (from 72.5%) * **Crop Insurance Premium:** **₹18 Cr** Q1 FY2026 vs. **₹1,425 Cr** in prior year ## B. Loss Ratio Trends * **Divergent Underwriting Performance:** Company outperformed a deteriorating industry, maintaining disciplined profitable growth despite sector-wide CoR pressures, especially in Motor. * **Q1 Margin Pressure:** CoR expansion in Q1 reflects adverse trends in Retail Health and timing impacts, though full-year trajectory remains subject to normalization. * **Inflation & Pricing Gaps:** Underwriting math challenged by inflation and lagging premium adjustments, particularly where third-party (TP) pricing remains inflexible. * **Aggressive Growth Backlash:** Peers’ past volume-focused strategies led to significant CoR deterioration, prompting strategic recalibration across the sector. ## C. Retail Health Incidence * **Enhanced Customer Support:** IL Sahayak initiative scaled significantly, supporting **over 28,000 customers** in Q1 FY2026 (vs. 8,000+ prior year), improving claim experience. * **Near-Term Loss Ratio Volatility:** Retail Health incidence rose YoY due to mix shifts, NEP, and frequency spikes, but management expects improvement as portfolio stabilizes. * **Back Book Concerns Acknowledged:** Elevated loss ratios in legacy Retail Health book above **65–70% target range** are recognized; recalibration underway. ## D. Fire Business Volatility * **Pricing Discipline vs. Volatility:** Fire business profitability remains uncertain due to high-severity, low-frequency risk, despite better pricing and underwriting control. * **Growth Constraints:** Fire line growth lagged industry despite market leadership, with Commercial lines concentration in Q1 raising questions on full-year trajectory. ## E. Aviation Claim Impact * **Claim Fully Provisioned:** Financial impact of the Air India-related aviation claim, including hull and personal accident components, is **fully absorbed in Q1 results** and within company’s risk capacity. * **No Standalone Disclosure:** Incident treated as part of normal course; no separate breakout provided, consistent with company’s claims policy. --- # 6. Regulatory & Industry Risks ## A. Regulatory Accounting Shift * **1/n Accounting Impact:** Q1 FY2026 results are **not comparable** to prior periods due to IRDAI-mandated 1/n accounting for long-term products effective October 1, 2024. * **Commission Restructuring:** Industry-wide shift to **1/n commission payout model** for long-term health policies alters distributor economics and may be influencing channel behavior. * **Fundamental Resilience:** Despite regulatory headwinds, health insurance fundamentals remain strong, supporting long-term growth potential. ## B. EoM Compliance & Strategic Pressure * **Unsustainable Losses:** Industry Combined Ratio at **124%** reflects unviable underwriting economics, with EoM compliance pressures amplifying strategic risks. * **Ongoing Regulatory Scrutiny:** Over **50% of insurers remain non-compliant** with the IRDAI’s EoM glide path thresholds, maintaining pressure on pricing and acquisition strategies. * **Behavioral Shifts:** Insurers may pursue **lower customer acquisition costs** and aggressive pricing to navigate the glide path, though such tactics risk worsening underlying profitability. ## C. Competitive Dynamics & Market Structure * **Elevated Competitive Intensity:** Motor and Group Health segments face persistent pressure, driven by **new entrants**, **uneven underwriting discipline**, and **cyclical volatility** shortening recovery windows. * **Pricing Rationalization Needed:** Executives affirm that **price increases are warranted** due to claim inflation and judicial awards, though outcomes depend on competitive response. * **Market Share Reallocation:** High EoM ratios among private players may enable PSU insurers to gain share via more competitive pricing. * **Resilient Positioning:** ICICI Lombard views competitive volatility as inherent and leverages its **multi-line, multi-product, multi-channel** model to navigate shifts. --- # 7. Guidance & Outlook ## A. Profitability & Industry Outlook * **Resilient Performance:** Sustained profitability amid sector headwinds, driven by data, technology, and the 'One IL One Team' philosophy. * **Retail Health Stabilization:** Loss ratio expected to stabilize within **65–70%** range for current year, in line with historical comfort levels. * **Cautious Growth Trajectory:** Management anticipates positive YoY growth in upcoming quarters if discounting stabilizes, with Q1 typically the strongest booking period. * **H2 Recovery Focus:** Efforts underway to close Q1 performance gap and reaccelerate momentum in second-half, supported by a normalized base. ## B. Market Share Strategy * **Selective Growth Posture:** No intent to pursue aggregate market share gains; focus remains on disciplined, segment-specific expansion despite competitive intensity. * **Shift in Competitive Dynamics:** Recent market share gains are now originating from PSU players, marking a reversal from prior private-sector-led aggression. * **Strategic Patience Emphasized:** Leadership expresses confidence in cyclical recovery, willing to wait out intense competition for future strategic opportunities. ## C. Crop Insurance Outlook * **Limited Near-Term Visibility:** Minimal Crop insurance bidding activity in current year; most opportunities expected in next financial year. * **Challenged Growth Outlook:** YoY growth in Crop insurance deemed unlikely at this stage due to sparse tenders and outcome uncertainty. ## D. Risk Selection & Underwriting Discipline * **Profitability Over Growth:** Strategy actively calibrated to avoid growth at the expense of underwriting discipline and margin integrity. * **Group Health Rebound Optionality:** Positioned to resume risk writing in Group Health if competitive EoM pressures ease and market conditions normalize.